Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.67 USD | +1.21% | -4.02% | +4.38% |
03-28 | Reneo Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
03-25 | North American Morning Briefing : Tech in Focus on -2- | DJ |
Business Summary
Number of employees: 8
Managers
Managers | Title | Age | Since |
---|---|---|---|
Niall O'Donnell
FOU | Founder | 51 | - |
Gregory Flesher
CEO | Chief Executive Officer | 54 | 08/12/20 |
Michael Grey
FOU | Founder | 71 | 21/09/14 |
Jennifer P. Lam
ADM | Chief Administrative Officer | - | 31/07/21 |
Michael Cruse
COO | Chief Operating Officer | 52 | 30/11/20 |
Chief Tech/Sci/R&D Officer | 64 | 31/12/17 | |
Ashley Hall
PRN | Corporate Officer/Principal | 52 | 10/10/21 |
Corporate Officer/Principal | - | 31/12/17 | |
Wendy Johnson
PRN | Corporate Officer/Principal | 72 | 31/12/16 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Michael Grey
FOU | Founder | 71 | 21/09/14 |
Director/Board Member | 64 | 30/11/17 | |
Paul Hoelscher
BRD | Director/Board Member | 59 | 19/01/22 |
Gregory Flesher
CEO | Chief Executive Officer | 54 | 08/12/20 |
Stacey Seltzer
BRD | Director/Board Member | 47 | 30/11/20 |
Niall O'Donnell
FOU | Founder | 51 | - |
Bali Muralidhar
BRD | Director/Board Member | 44 | 31/03/21 |
Roshawn Blunt
BRD | Director/Board Member | 49 | 31/12/21 |
Eric Dube
BRD | Director/Board Member | 51 | 14/03/21 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 33,420,808 | 32,416,707 ( 97.00 %) | 0 | 97.00 % |
Company contact information
Sector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+4.38% | 55.81M | |
+1.51% | 42.75B | |
+49.22% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- RPHM Stock
- Company Reneo Pharmaceuticals, Inc.